Trihexyphenidyl

DEA Class;  Rx

Common Brand Names; Artane, Trihex

  • Antiparkinson Agents, Anticholinergics
 

An oral synthetic, tertiary antimuscarinic that penetrates the central nervous system (CNS)
Indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic); often useful as adjuvant therapy with levodopa
Also helps control of extrapyramidal disorders due to CNS drugs (e.g., phenothiazines, thioxanthenes, and butyrophenones)

Indicated for the treatment of idiopathic parkinsonism or Parkinson’s disease.

For the treatment of drug-induced extrapyramidal symptoms

For the treatment of clozapine-induced sialorrhea† (drooling).

Hypersensitivity

Angle-closure glaucoma

  • Anticholinergic side effects (30-50%)
  • Rash
  • Suppurative parotitis
  • Hallucination
  • Paralytic ileus

Exacerbation of parkinsonism, neuroleptic malignant syndrome, and withdrawal symptoms associated with therapy discontinuation or dose reduction; drug should be withdrawn gradually

Perform gonioscope evaluation before initiating treatment; monitor intraocular pressure closely at regular periodic intervals

Therapy may impair memory and exacerbate cognitive deficits in the elderly; may also cause delirium, hallucinations, and confusion when administered at high doses

Use extreme caution and monitor closely patients with liver, cardiac, kidney disorders, prostatic hyperplasia (urinary stricture), or with hypertension

Pregnancy Category: C

Lactation: no data; may inhibit lactation

Adults

15 mg/day PO.

Elderly

15 mg/day PO.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Trihexyphenidyl hydrochloride 

tablets

  • 2mg
  • 5mg

elixir

  • 0.4mg/mL

About the Author

You may also like these

0